The US Food and Drug Administration (FDA) approved Vivus Inc`s obesity drug, Qsymia, on Tuesday, giving a new hope to people fighting excessive weight gain problem.
The approval follows last month`s go-ahead for Arena Pharmaceuticals` Belviq. The FDA had previously delayed its decision on the weight-loss pill by three months to review the company`s plan for reducing risks, such as birth defects and elevated heart rate.
Bariatric SurgeryWith about two-thirds of Americans considered obese, the FDA has been under constant pressure to approve new weight loss treatments.
Weight Loss SurgeryThe FDA approved the pill for use in obese adults, and in overweight adults who have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol."Qsymia, used responsibly in combination with a healthy lifestyle that includes a reduced calorie diet and exercise, provides another treatment option for chronic weight management in Americans who are obese or are overweight and have at least one weight-related comorbid condition," Dr. Janet Woodcock, director of FDA`s Centre for Drug Evaluation and Research, said in a statement.
Fat Chance: Diet Coke Fights Obesity?
For related articles and more information, please visit OCA's Food Safety page and our Millions Against Monsanto page.
Overweight 6-Year-Old Vows To Change Lifestyle After Second Heart Attack
HOUSTON—Describing his second heart failure in the span of two years as “a real wake up call,” obese 6-year-old Nicholas Bleyer announced Tuesday that he was finally trying to turn his life around.
Obesity rates rise in county schools
By the time students in Forsyth County reach high school, more than 40 percent of them are overweight or obese, according to a BMI study released by Winston-Salem/Forsyth County Schools.
